Diagnostic and Prognostic Value of Immune/Inflammation Biomarkers for Venous Thromboembolism: Is It Reliable for Clinical Practice?

References

• Wendelboe AM, Raskob GE. Global burden of thrombosis: epidemiologic aspects. Circ Res. 2016;118(9):1340–1347. doi:10.1161/CIRCRESAHA.115.306841
   PubMed Web of Science ®Google Scholar
• Bhat TM, Afari ME, Garcia LA. Neutrophil lymphocyte ratio in peripheral vascular disease: a review. Expert Rev Cardiovasc Ther. 2016;14(7):871–875. doi:10.1586/14779072.2016.1165091
   PubMed Web of Science ®Google Scholar
• Mozos I, Malainer C, Horbanczuk J, et al. Inflammatory markers for arterial stiffness in cardiovascular diseases. Front Immunol. 2017;8:1058. doi:10.3389/fimmu.2017.01058
   PubMed Web of Science ®Google Scholar
• Teperman J, Carruthers D, Guo Y, et al. Relationship between neutrophil-lymphocyte ratio and severity of lower extremity peripheral artery disease. Int J Cardiol. 2017;228:201–204. doi:10.1016/j.ijcard.2016.11.097
   PubMed Web of Science ®Google Scholar
• Kremers B, Wubbeke L, Mees B, et al. Plasma biomarkers to predict cardiovascular outcome in patients with peripheral artery disease: a systematic review and meta-analysis. Arterioscler Thromb Vasc Biol. 2020;40(9):2018–2032. doi:10.1161/ATVBAHA.120.314774
   PubMed Web of Science ®Google Scholar
• Neupane R, Jin X, Sasaki T, et al. Immune Disorder in Atherosclerotic Cardiovascular Disease- Clinical Implications of Using Circulating T-Cell Subsets as Biomarkers. Circ J. 2019;83(7):1431–1438. doi:10.1253/circj.CJ-19-0114
   PubMed Web of Science ®Google Scholar
• Ates H, Ates I, Kundi H, Yilmaz FM. Diagnostic validity of hematologic parameters in evaluation of massive pulmonary embolism. J Clin Lab Anal. 2017;31(5):e22072. doi:10.1002/jcla.22072
   PubMed Web of Science ®Google Scholar
• Ates H, Ates I, Bozkurt B, et al. What is the most reliable marker in the differential diagnosis of pulmonary embolism and community-acquired pneumonia? Blood Coagul Fibrinolysis. 2016;27(3):252–258. doi:10.1097/MBC.0000000000000391
   PubMed Web of Science ®Google Scholar
• Kose N, Yildirim T, Akin F, Yildirim SE, Altun I. Prognostic role of NLR, PLR, and LMR in patients with pulmonary embolism. Bosn J Basic Med Sci. 2020;20(2):248–253.
   PubMed Web of Science ®Google Scholar
• Celik A, Ozcan IT, Gundes A, et al. Usefulness of admission hematologic parameters as diagnostic tools in acute pulmonary embolism. Kaohsiung J Med Sci. 2015;31(3):145–149. doi:10.1016/j.kjms.2014.12.004
   PubMed Web of Science ®Google Scholar
• Akgullu C, Omurlu IK, Eryilmaz U, et al. Predictors of early death in patients with acute pulmonary embolism. Am J Emerg Med. 2015;33(2):214–221. doi:10.1016/j.ajem.2014.11.022
   PubMed Web of Science ®Google Scholar
• Soylu K, Gedikli O, Eksi A, et al. Neutrophil-to-lymphocyte ratio for the assessment of hospital mortality in patients with acute pulmonary embolism. Arch Med Sci. 2016;12(1):95–100. doi:10.5114/aoms.2016.57585
   PubMed Web of Science ®Google Scholar
• Bi W, Liang S, He Z, et al. The Prognostic Value of the Serum Levels of Brain Natriuretic Peptide, Troponin I, and D-Dimer, in Addition to the Neutrophil-to-Lymphocyte Ratio, for the Disease Evaluation of Patients with Acute Pulmonary Embolism. Int J Gen Med. 2021;14:303–308. doi:10.2147/IJGM.S288975
   PubMed Web of Science ®Google Scholar
• Kasapoglu US, Olgun YS, Arikan H, et al. Comparison of neutrophil to lymphocyte ratio with other prognostic markers affecting 30 day mortality in acute pulmonary embolism. Tuberk Toraks. 2019;67(3):179–189. doi:10.5578/tt.68519
   PubMed Web of Science ®Google Scholar
• Kayrak MB, Erdogan HI, Solak Y, et al. Prognostic value of neutrophil to lymphocyte ratio in patients with acute pulmonary embolism: a restrospective study. Heart Lung Circ. 2014;23(1):56–62. doi:10.1016/j.hlc.2013.06.004
   PubMed Web of Science ®Google Scholar
• Ma Y, Mao Y, He X, et al. The values of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in predicting 30 day mortality in patients with acute pulmonary embolism. BMC Cardiovasc Disord. 2016;16:123. doi:10.1186/s12872-016-0304-5
   PubMed Web of Science ®Google Scholar
• Liu C, Zhan HL, Huang ZH, et al. Prognostic role of the preoperative neutrophil-to-lymphocyte ratio and albumin for 30-day mortality in patients with postoperative acute pulmonary embolism. BMC Pulm Med. 2020;20(1):180. doi:10.1186/s12890-020-01216-5
   PubMed Web of Science ®Google Scholar
• Jia D, Liu F, Zhang Q, et al. Rapid on-site evaluation of routine biochemical parameters to predict right ventricular dysfunction in and the prognosis of patients with acute pulmonary embolism upon admission to the emergency room. J Clin Lab Anal. 2018;32(4):e22362. doi:10.1002/jcla.22362
   PubMed Web of Science ®Google Scholar
• Telo S, Kuluozturk M, Deveci F, Kirkil G. The relationship between platelet-to-lymphocyte ratio and pulmonary embolism severity in acute pulmonary embolism. Int Angiol. 2019;38(1):4–9. doi:10.23736/S0392-9590.18.04028-2
   PubMed Web of Science ®Google Scholar
• Phan T, Brailovsky Y, Fareed J, et al. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios predict all-cause mortality in acute pulmonary embolism. Clin Appl Thromb Hemost. 2020;26:1076029619900549. doi:10.1177/1076029619900549
   Web of Science ®Google Scholar
• Duman D, Sonkaya E, Yildirim E, et al. Association of inflammatory markers with mortality in patients hospitalized with non-massive pulmonary embolism. Turk Thorac J. 2021;22(1):24–30. doi:10.5152/TurkThoracJ.2021.190076
   PubMed Web of Science ®Google Scholar
• MB Karataş, İpek G, Onuk T, et al. Assessment of prognostic value of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in patients with pulmonary embolism. Acta Cardiol Sin. 2016;3(32):313–320.
   Google Scholar
• Ghaffari S, Parvizian N, Pourafkari L, et al. Prognostic value of platelet indices in patients with acute pulmonary thromboembolism. J Cardiovasc Thorac Res. 2020;12(1):56–62. doi:10.34172/jcvtr.2020.09
   PubMed Web of Science ®Google Scholar
• Ertem AG, Yayla C, Acar B, et al. Relation between lymphocyte to monocyte ratio and short-term mortality in patients with acute pulmonary embolism. Clin Respir J. 2018;12(2):580–586. doi:10.1111/crj.12565
   PubMed Web of Science ®Google Scholar
• Farah R, Nseir W, Kagansky D, Khamisy-Farah R. The role of neutrophil-lymphocyte ratio, and mean platelet volume in detecting patients with acute venous thromboembolism. J Clin Lab Anal. 2020;34(1):e23010. doi:10.1002/jcla.23010
   PubMed Web of Science ®Google Scholar
• Artoni A, Abbattista M, Bucciarelli P, et al. Platelet to lymphocyte ratio and neutrophil to lymphocyte ratio as risk factors for venous thrombosis. Clin Appl Thromb Hemost. 2018;24(5):808–814. doi:10.1177/1076029617733039
   PubMed Web of Science ®Google Scholar
• Fuentes HE, Paz LH, Wang Y, et al. Performance of current thromboembolism risk assessment tools in patients with gastric cancer and validity after first treatment. Clin Appl Thromb Hemost. 2018;24(5):790–796. doi:10.1177/1076029617726599
   PubMed Web of Science ®Google Scholar
• Yao C, Zhang Z, Yao Y, et al. Predictive value of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio for acute deep vein thrombosis after total joint arthroplasty: a retrospective study. J Orthop Surg Res. 2018;13(1):40. doi:10.1186/s13018-018-0745-x
   PubMedGoogle Scholar
• Seo WW, Park MS, Kim SE, et al. Neutrophil-Lymphocyte Ratio as a Predictor of Venous Thromboembolism after Total Knee Replacement. J Knee Surg. 2021;34(2):171–177. doi:10.1055/s-0039-1694043
   PubMedGoogle Scholar
• Barker T, Rogers VE, Henriksen VT, et al. Is there a link between the neutrophil-to-lymphocyte ratio and venous thromboembolic events after knee arthroplasty? A pilot study. J Orthop Traumatol. 2016;17(2):163–168. doi:10.1007/s10195-015-0378-3
   PubMedGoogle Scholar
• Peng J, Wang H, Zhang L, Lin Z. Construction and efficiency analysis of prediction model for venous thromboembolism risk in the elderly after hip fracture. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2021;46(2):142–148.
   PubMedGoogle Scholar
• Grimnes G, Horvei LD, Tichelaar V, Braekkan SK, Hansen JB. Neutrophil to lymphocyte ratio and future risk of venous thromboembolism and mortality: the Tromso Study. Haematologica. 2016;101(10):e401–e404. doi:10.3324/haematol.2016.145151
   PubMed Web of Science ®Google Scholar
• Grilz E, Posch F, Konigsbrugge O, et al. Association of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio with the risk of thromboembolism and mortality in patients with cancer. Thromb Haemost. 2018;118(11):1875–1884. doi:10.1055/s-0038-1673401
   PubMed Web of Science ®Google Scholar
• Ming L, Jiang Z, Ma J, et al. Platelet-to-lymphocyte ratio, neutrophil-to-lymphocyte ratio, and platelet indices in patients with acute deep vein thrombosis. Vasa. 2018;47(2):143–147. doi:10.1024/0301-1526/a000683
   PubMed Web of Science ®Google Scholar
• Ferroni P, Riondino S, Formica V, et al. Venous thromboembolism risk prediction in ambulatory cancer patients: clinical significance of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio. Int J Cancer. 2015;136(5):1234–1240. doi:10.1002/ijc.29076
   PubMed Web of Science ®Google Scholar
• Go SI, Lee A, Lee US, et al. Clinical significance of the neutrophil-lymphocyte ratio in venous thromboembolism patients with lung cancer. Lung Cancer. 2014;84(1):79–85. doi:10.1016/j.lungcan.2014.01.014
   PubMed Web of Science ®Google Scholar
• Yanartas M, Kalkan ME, Arslan A, et al. Neutrophil/Lymphocyte Ratio Can Predict Postoperative Mortality in Patients with Chronic Thromboembolic Pulmonary Hypertension. Ann Thorac Cardiovasc Surg. 2015;21(3):229–235. doi:10.5761/atcs.oa.14-00190
   PubMed Web of Science ®Google Scholar
• Kurtipek E, Buyukterzi Z, Buyukterzi M, Alpaydin MS, Erdem SS. Endothelial dysfunction in patients with pulmonary thromboembolism: neutrophil to lymphocyte ratio and platelet to lymphocyte ratio. Clin Respir J. 2017;11(1):78–82. doi:10.1111/crj.12308
   PubMed Web of Science ®Google Scholar
• Kuplay H, Erdogan SB, Bastopcu M, et al. The neutrophil-lymphocyte ratio and the platelet-lymphocyte ratio correlate with thrombus burden in deep venous thrombosis. J Vasc Surg Venous Lymphat Disord. 2020;8(3):360–364. doi:10.1016/j.jvsv.2019.05.007
   PubMedGoogle Scholar
• Bakirci EM, Topcu S, Kalkan K, et al. The role of the nonspecific inflammatory markers in determining the anatomic extent of venous thromboembolism. Clin Appl Thromb Hemost. 2015;21(2):181–185. doi:10.1177/1076029613494469
   PubMed Web of Science ®Google Scholar
• Jahangiri Y, Endo M, Al-Hakim R, Kaufman JA, Farsad K. Early venous stent failure predicted by platelet count and neutrophil/lymphocyte ratio. Circ J. 2019;83(2):320–326. doi:10.1253/circj.CJ-18-0592
   PubMed Web of Science ®Google Scholar
• Kushnir M, Cohen HW, Billett HH. Persistent neutrophilia is a marker for an increased risk of venous thrombosis. J Thromb Thrombolysis. 2016;42(4):545–551. doi:10.1007/s11239-016-1398-4
   PubMed Web of Science ®Google Scholar
• Mareev VY, Orlova YA, Pavlikova EP, et al. [Steroid pulse -therapy in patients With coronAvirus Pneumonia (COVID-19), sYstemic inFlammation And Risk of vEnous thRombosis and thromboembolism (WAYFARER Study)]. Kardiologiia. 2020;60(6):15–29. doi:10.18087/cardio.2020.6.n1226. Esperanto.
   PubMed Web of Science ®Google Scholar
• Li SH, Wang QX, Yang ZY, et al. Prognostic value of the neutrophil-to-lymphocyte ratio for hepatocellular carcinoma patients with portal/hepatic vein tumor thrombosis. World J Gastroenterol. 2017;23(17):3122–3132. doi:10.3748/wjg.v23.i17.3122
   PubMed Web of Science ®Google Scholar
• Kundi H, Balun A, Cicekcioglu H, et al. The relation between platelet-to-lymphocyte ratio and Pulmonary Embolism Severity Index in acute pulmonary embolism. Heart Lung. 2015;44(4):340–343. doi:10.1016/j.hrtlng.2015.04.007
   PubMed Web of Science ®Google Scholar
• Yamagata K, Fukuzawa S, Uchida F, et al. Is Preoperative Plate-Lymphocyte Ratio a Predictor of Deep Vein Thrombosis in Patients With Oral Cancer During Surgery? J Oral Maxillofac Surg. 2021;79(4):914–924. doi:10.1016/j.joms.2020.10.024
   PubMed Web of Science ®Google Scholar
• Yang W, Liu Y. Platelet-lymphocyte ratio is a predictor of venous thromboembolism in cancer patients. Thromb Res. 2015;136(2):212–215. doi:10.1016/j.thromres.2014.11.025
   PubMed Web of Science ®Google Scholar
• Fuentes HE, Oramas DM, Paz LH, et al. Venous thromboembolism is an independent predictor of mortality among patients with gastric cancer. J Gastrointest Cancer. 2018;49(4):415–421. doi:10.1007/s12029-017-9981-2
   PubMed Web of Science ®Google Scholar
• Tham T, Rahman L, Persaud C, Olson C, Costantino P. Venous thromboembolism risk in head and neck cancer: significance of the preoperative platelet-to-lymphocyte ratio. Otolaryngol Head Neck Surg. 2018;159(1):85–91. doi:10.1177/0194599818756851
   PubMed Web of Science ®Google Scholar
• Wang Q, Ma J, Jiang Z, Ming L. Prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in acute pulmonary embolism: a systematic review and meta-analysis. Int Angiol. 2018;37(1):4–11. doi:10.23736/S0392-9590.17.03848-2
   PubMed Web of Science ®Google Scholar
• Rojnuckarin P, Uaprasert N, Sriuranpong V. Monocyte count associated with subsequent symptomatic venous thromboembolism (VTE) in hospitalized patients with solid tumors. Thromb Res. 2012;130(6):e279–82. doi:10.1016/j.thromres.2012.09.015
   PubMed Web of Science ®Google Scholar
• Wypasek E, Padjas A, Szymanska M, et al. Non-classical and intermediate monocytes in patients following venous thromboembolism: links with inflammation. Adv Clin Exp Med. 2019;28(1):51–58. doi:10.17219/acem/76262
   PubMed Web of Science ®Google Scholar
• Maldonado-Pena J, Rivera K, Ortega C, et al. Can monocytosis act as an independent variable for predicting deep vein thrombosis? Int J Cardiol. 2016;219:282–284. doi:10.1016/j.ijcard.2016.06.020
   PubMed Web of Science ®Google Scholar
• Basavaraj MG, Braekkan SK, Brodin E, Osterud B, Hansen JB. Monocyte count and procoagulant functions are associated with risk of venous thromboembolism: the Tromso study. J Thromb Haemost. 2011;9(8):1673–1676. doi:10.1111/j.1538-7836.2011.04411.x
   PubMed Web of Science ®Google Scholar
• Go SI, Kim RB, Song HN, et al. Prognostic significance of the absolute monocyte counts in lung cancer patients with venous thromboembolism. Tumour Biol. 2015;36(10):7631–7639. doi:10.1007/s13277-015-3475-2
   PubMedGoogle Scholar
• Lopez-Salazar J, Ramirez-Tirado LA, Gomez-Contreras N, et al. Cancer-associated prothrombotic pathways: leucocytosis, but not thrombocytosis, correlates with venous thromboembolism in women with ovarian cancer. Intern Med J. 2020;50(3):366–370. doi:10.1111/imj.14762
   PubMed Web of Science ®Google Scholar
• Chirinos JA, Heresi GA, Velasquez H, et al. Elevation of endothelial microparticles, platelets, and leukocyte activation in patients with venous thromboembolism. J Am Coll Cardiol. 2005;45(9):1467–1471. doi:10.1016/j.jacc.2004.12.075
   PubMed Web of Science ®Google Scholar
• Shih L, Kaplan D, Kraiss LW, et al. Platelet-Monocyte Aggregates and C-Reactive Protein are Associated with VTE in Older Surgical Patients. Sci Rep. 2016;6:27478. doi:10.1038/srep27478
   PubMed Web of Science ®Google Scholar
• Cannon NA, Meyer J, Iyengar P, et al. Neutrophil-lymphocyte and platelet-lymphocyte ratios as prognostic factors after stereotactic radiation therapy for early-stage non-small-cell lung cancer. J Thorac Oncol. 2015;10(2):280–285. doi:10.1097/JTO.0000000000000399
   PubMed Web of Science ®Google Scholar
• Dolan RD, McSorley ST, Park JH, et al. The prognostic value of systemic inflammation in patients undergoing surgery for colon cancer: comparison of composite ratios and cumulative scores. Br J Cancer. 2018;119(1):40–51. doi:10.1038/s41416-018-0095-9
   PubMed Web of Science ®Google Scholar
• Wang BL, Tian L, Gao XH, et al. Dynamic change of the systemic immune inflammation index predicts the prognosis of patients with hepatocellular carcinoma after curative resection. Clin Chem Lab Med. 2016;54(12):1963–1969. doi:10.1515/cclm-2015-1191
   PubMed Web of Science ®Google Scholar
• Gok M, Kurtul A. A novel marker for predicting severity of acute pulmonary embolism: systemic immune-inflammation index. Scand Cardiovasc J. 2021;55(2):91–96. doi:10.1080/14017431.2020.1846774
   PubMed Web of Science ®Google Scholar
• Liu Y, Meng X, Feng J, Zhou X, Zhu H. Hypereosinophilia with concurrent venous thromboembolism: clinical features, potential risk factors, and short-term outcomes in a Chinese cohort. Sci Rep. 2020;10(1):8359. doi:10.1038/s41598-020-65128-4
   PubMed Web of Science ®Google Scholar
• Reau V, Vallee A, Terrier B, et al. Venous thrombosis and predictors of relapse in eosinophil-related diseases. Sci Rep. 2021;11(1):6388. doi:10.1038/s41598-021-85852-9
   PubMed Web of Science ®Google Scholar
• Kovacs S, Csiki Z, Zsori KS, Bereczky Z, Shemirani AH. Characteristics of platelet count and size and diagnostic accuracy of mean platelet volume in patients with venous thromboembolism. A systematic review and meta-analysis. Platelets. 2019;30(2):139–147. doi:10.1080/09537104.2017.1414175
   PubMed Web of Science ®Google Scholar